Modafinil for drooling in cerebral palsy

Journal of Child Neurology

Volumn 21, Issue 2, 2006, Pages 112-114

  Hurst, Daniel ^a   Cedrone, Nona ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CARBAMAZEPINE; MODAFINIL;

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CEREBRAL PALSY; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; EPILEPSY; FOLLOW UP; HUMAN; HYPERSALIVATION; MALE; MOTOR COORDINATION; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; SPASTICITY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ARTICULATION DISORDERS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL PALSY; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROLOGIC EXAMINATION; PSYCHOMOTOR PERFORMANCE; SIALORRHEA;

EID: 33646826968     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210021801     Document Type: Article

References (25)

1. Nelson KB: Epidemiology of Cerebral Palsy in the Year 2000. Presented at the 29th annual meeting of the Child Neurology Society, St. Louis, MO, October 28, 2000.
2. Jongerius PH, Rotteveel JJ, van den Hoogen FJA, et al: Botulinum toxin A: A new Option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 2001;160:509-512.
3. Bothwell JE, Clarke K, Dooley JM, et al: Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol 2002;27:18-22.
4. Suskind DL, Tilton A: Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73-81.
5. Jongerius PH, Rotteveel JJ, van Limbeek J, et al: Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 2004;63:1371-1375.
6. Jongerius PH, Joosten F, van den Hoogen FJA, et al: The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 2003;113:107-111.
7. Hurst DL, Lajara-Nanson W: Use of modafinil in spastic cerebral palsy. J Child Neurol 2002;17:169-172.
8. Hurst DL, Lajara-Nanson WA, Dinakar P, et al: Retrospective review of modafinil use for cerebral palsy. J Child Neurol 2004;19:948-951.
9. Haerer AF: The glossopharyngeal and vagus nerves, in Haerer AF (ed): DeJong's The Neurologic Examination, 5th ed. Philadelphia, JB Lippincott, 1992, 227-242.
10. Haerer AF: Chronic medullary syndromes, in Haerer AF (ed): DeJong's The Nearologic Examination, 5th ed. Philadelphia, JB Lippincott, 1992, 266-267.
11. Fenichel GM: Spastic quadriplegia, in Fenichel GM (ed): Clinical Pediatric Neurology: A Sign and Symptoms Approach, 4th ed. Philadelphia, WB Saunders, 2001, 272.
12. Senner JE, Logemann J, Zecker S, et al: Drooling, saliva production, and swallowing in cerebral palsy. Dev Med Child Neurol 2004;46:801-806.
13. Volonte MA, Porta M, Comi G: Clinical assessment of dysphagia in early phases of Parkinson's disease. Neurol Sci 2002;23(Suppl 2):S121-S122.
14. Proulx M, De Courval FP, Wiseman MA, et al: Salivary production in Parkinson's disease. Mov Disord 2005;20:204-207.
15. Prosiegel M, Schelling A, Wagner-Sonntag E: Dysphagia and multiple sclerosis. Int MS J 2004;11:22-31.
16. Merson RM, Rolnick MI: Speech-language pathology and dysphagia in multiple sclerosis. Phys Med Rehabil Clin N Am 1998;9: 631-641.
17. Thompson AJ: Multiple sclerosis: Symptomac treatment. J Neurol 1996;243:559-565.
18. Moldofsky H, Broughton RJ, Hill JD: A randomized trial of the long-term continued efficacy and safety of modafinil in narcolepsy. Sleep Med 2000;1:109-116.
19. Broughton RJ, Fleming JAE, George CFP, et al: Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997;49:444-451.
20. US Modafinil in Narcolepsy Multicenter Study Group: Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97.
21. Rugino TA, Copley TC: Effects of modafinil in children with attention-deficit hyperactivity disorder: An open-label study. J Am Acad Child Adolesc Psychiatry 2001;40:230-235.
22. Milla PJ, Jackson ADM: A controlled trial of baclofen in children with cerebral palsy. J Int Med Res 1977;5:398-404.
23. Gilmartin R, Bruce D, Storrs B, et al: Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial. J Child Neurol 2000;15:71-77.
24. Parks TS, Owen JH: Surgical management of spastic diplegia in cerebral palsy N Engl J Med 1992;326:745-749.
25. Fehlings D, Rang M, Glazier J, et al: An evaluation of botulinum A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr 2000;137:331-337.